Xarelto Class Action Filed by Canadian Attorney Who Predicts More to Come

Published on March 9, 2015 by Sandy Liebhard

Text-Size:A A A+


A Xarelto lawsuit alleging episodes of uncontrollable internal bleeding has been filed in Calgary by a Canadian attorney who says that several others will be soon to follow.

He told the Calgary Sun on February 13th that the first class action case has already been filed in Calgary, and is being represented by a woman who nearly suffered cardiac arrest in September 2012 after she began bleeding internally. The Xarelto attorney asserts in the claim that “The health care professionals who were treating Betty for this hemorrhaging had considerable difficulty in stopping her bleeding,” and that the plaintiff could be awarded millions in damages.

Also included in this Xarelto internal bleeding lawsuit are the results of a German report that found 130 Xarelto-related deaths in 2012 and 2013, and more than 1,100 adverse event reports filed in Health Canada’s database. A dozen of the adverse event reports filed with the Canadian regulator mentioned death, the claim states.

In addition to the Xarelto lawsuit in Calgary, a similar action involving the anticoagulant is on the road to being filed in Ontario. There, a 83-year old woman suffered a fatal episode of internal bleeding episode.

Xarelto Litigation Builds in Eastern District of Louisiana

As the litigation surrounding this blood thinner continues to mount in Canada, more claims are being filed in the U.S. A federal litigation involving similar claims over the medication, which is jointly manufactured by Bayer Healthcare and the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, was created in December 2014, court document indicate. There are now more than 220 Xarelto lawsuits now pending in the proceeding, which has been established in the U.S. District Court, Eastern District of Louisiana.

Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011, and belongs to a class of new-generation anticoagulants referred to as direct thrombin inhibitors. Since then, Bayer and Janssen have marketed the treatment as a convenient alternative to warfarin, a similar drug that has been prescribed for decades.

Considering a Xarelto Lawsuit? Call our Firm.

Call a Xarelto lawyer today for more about claims that allege uncontrollable bleeding episodes and other complications caused by the blood thinner. Start the legal process today when you dial .

Web Analytics